
Gain Therapeutics: Focused on developing new medicines for protein misfolding diseases
In an engaging interview, journalist Jane King from LilaMax Media discusses cutting-edge allosteric therapies with Gain Therapeutics’ CEO, Matthias Alder, and their potential in